76 related articles for article (PubMed ID: 15177457)
1. Synthesis and biological activity of some known and putative duloxetine metabolites.
Kuo F; Gillespie TA; Kulanthaivel P; Lantz RJ; Ma TW; Nelson DL; Threlkeld PG; Wheeler WJ; Yi P; Zmijewski M
Bioorg Med Chem Lett; 2004 Jul; 14(13):3481-6. PubMed ID: 15177457
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Simoni D; Rossi M; Bertolasi V; Roberti M; Pizzirani D; Rondanin R; Baruchello R; Invidiata FP; Tolomeo M; Grimaudo S; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
J Med Chem; 2005 May; 48(9):3337-43. PubMed ID: 15857139
[TBL] [Abstract][Full Text] [Related]
4. Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
Boot JR; Brace G; Delatour CL; Dezutter N; Fairhurst J; Findlay J; Gallagher PT; Hoes I; Mahadevan S; Mitchell SN; Rathmell RE; Richards SJ; Simmonds RG; Wallace L; Whatton MA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5395-9. PubMed ID: 15454233
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of meperidine analogues at monoamine transporters.
Lomenzo SA; Rhoden JB; Izenwasser S; Wade D; Kopajtic T; Katz JL; Trudell ML
J Med Chem; 2005 Mar; 48(5):1336-43. PubMed ID: 15743177
[TBL] [Abstract][Full Text] [Related]
6. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter.
McConathy J; Owens MJ; Kilts CD; Malveaux EJ; Camp VM; Votaw JR; Nemeroff CB; Goodman MM
Nucl Med Biol; 2004 Aug; 31(6):705-18. PubMed ID: 15246361
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.
Patrick KS; Williard RL; VanWert AL; Dowd JJ; Oatis JE; Middaugh LD
J Med Chem; 2005 Apr; 48(8):2876-81. PubMed ID: 15828826
[TBL] [Abstract][Full Text] [Related]
9. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
10. Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter.
Cao J; Lever JR; Kopajtic T; Katz JL; Pham AT; Holmes ML; Justice JB; Newman AH
J Med Chem; 2004 Dec; 47(25):6128-36. PubMed ID: 15566284
[TBL] [Abstract][Full Text] [Related]
11. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry.
Schenk JO; Wright C; Bjorklund N
J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
Zhang S; Zhen J; Reith ME; Dutta AK
J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma.
Satonin DK; McCulloch JD; Kuo F; Knadler MP
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):582-9. PubMed ID: 17350901
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA
J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter network and pathways.
Maiya R; Mayfield RD
Int Rev Neurobiol; 2004; 61():79-96. PubMed ID: 15482812
[No Abstract] [Full Text] [Related]
18. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Kimura M; Masuda T; Yamada K; Kawakatsu N; Kubota N; Mitani M; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem Lett; 2004 Aug; 14(16):4287-90. PubMed ID: 15261288
[TBL] [Abstract][Full Text] [Related]
20. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]